OCT 2012

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/87458

Contents of this Issue


Page 43 of 168

Epithelial Xlinkin , PRK Xlinking g, PRK lessons that they've learned," Dr. Cunningham said. This will be followed by an afternoon device panel on emerging drug delivery technologies. A second device panel will highlight the current status and promise of premium IOLs and will be followed by a pharma talk on "Developing an Ophthalmic Pipeline." The afternoon will be capped off by a talk that Dr. Cunningham said should definitely engender some debate. "We're going to end the meeting with Jim Mazzo, president of AMO [Abbott Medical Optics, Santa Ana, Calif.], who is going to talk about the impact of the presidential election on innovation in the U.S. and beyond," Dr. Cunningham said. From the start he believes the meeting has satisfied a need not met elsewhere. "I think it was simply bringing all of the constituents together in one place who have an interest in developing new drugs and devices for treating ophthalmic disease and letting them see the hottest companies and technologies and hear what the issues are," Dr. Cunningham said. Dr. Lindstrom sees the summit as an excellent networking opportu- nity. "I would like doctors to take away five or six new contacts who would be useful in the future to whatever it is that they have as their primary goal, whether that be bringing one of their ideas to market or participating in bringing someone else's ideas to market," Dr. Lindstrom said. To learn more, go to www.ophthalmologysummit.com. EW Editors' note: Dr. Cunningham has fi- nancial interests with Clarus Ventures, Ophthotech (Princeton, N.J.), Aerie Pharmaceuticals (Bridgewater, N.J.), and SARcode Bioscience (Brisbane, Calif.). Dr. Lindstrom has financial interests with AMO, Bausch + Lomb (Rochester, N.Y.), multiple startups, Focus Ventures (Palo Alto, Calif.), Strathspey Crown (Newport Beach, Calif.), Versant Ventures (San Francisco), and Schroder Venture Life Sciences (SVLS, Boston). Contact information Cunningham: 650-238-5014, ecunningham@clarusventures.com Lindstrom: 952-567-6051, rllindstrom@mneye.com & Ad ance Surfrfface Abblattion.. Remove the ov Epithe iu in 5 to 7 secondsn Promotes Consistent Results! Consiste n Results! ntt + Minimize total procedure tim + Essential in re-treatments + Uniform epithelium removal o + No need for subsequent scraping e time Epitheliuml m seco ds. & Advancedd Su aceA la ion Ep ithelia l removal in Corneal Su pe iorResult s Chicago fun facts Chicago is home to nearly 200 art galleries The original Ferris wheel was built on the midway of the 1893 World's Columbian Exposition in Chicago Source: Explore Chicago T. 800.461.1200 61.1200 | www.inno vativexcimer .com Superrior Results

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - OCT 2012